Bath & Body Works remains a Strong Buy: fundamental improvements and robust cash flow make its implied valuation discount difficult to justify. BBWI's lowered $600 million free cash flow guidance still implies a ~16% yield; a very cautious DCF values shares at $27.94 versus $19.16. Debt repayments strengthen BBWI's balance sheet and open the door to substantial buybacks, including a new $500 million authorization.








